IDH1 wt Allele

Clinical trial pipeline · Data from ClinicalTrials.gov

See which IDH1 wt Allele trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT03896568

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

This phase I trial studies best dose and side effects of oncolytic adenovirus DNX-2401 in treating patients with high-grade glioma that has come back (recurrent…

United States36 participantsStarted 2019-02-12

Treatment: Oncolytic Adenovirus Ad5-DNX-2401, Therapeutic Conventional Surgery

IDH1 wt Allele

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

All recent trials (1 shown)